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For: Challenges of Miniaturization and Automation in Bioprocess Development  
 
The recent developments within the biopharmaceutical market change the demands and requirements that have 
to be addressed. The venture of biosimilars and biobetters based on the off-patent situation enhances the need 
for acceleration of process development with high flexibility for new products. The trend toward PAT and 
continuous processing raises the need for better process understanding and integrated process development 
which challenges both - up and downstream processing. Bacterial systems offer high advantages and flexibility 
for high yield overexpression but often end up in very complex processes during product recovery.  Often 
overexpression in E.coli is therefore limited to soluble fractions which means a severe limitation and restricts the 
opportunity to succeed. This talk present a HTS platform to evaluate the entire process of proteins expressed in 
E. coli as inclusion bodies – directly connecting DoE screening in upstream development to the subsequent 
downstream process including cell disruption, IB preparation and protein capture. This fast and material saving 
platform method provides a high-quality evaluation of fermentation screenings and reduces the initial barrier and 
reservation for IB processes opening potential for new products. As additional benefit you will generate valuable 
knowledge and gain better understanding of your process on the way. 
 
